StockSelector.com
  Research, Select, & Monitor Sunday, May 26, 2019 7:58:07 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Dicerna Pharmaceuticals Inc$12.49$.665.58%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Dicerna Pharmaceuticals Inc has an overall rank of 6001 out of 6809 stocks based on 6 positive rankings and 10 negative rankings.

Positive Rankings
Estimated Revenue Growth
Dicerna Pharmaceuticals Inc rank is 53
Target Prices
The average analysts' target price is $30.00 for Dicerna Pharmaceuticals Inc using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Dicerna Pharmaceuticals Inc is ranked 62.
10 Day Gain
Dicerna Pharmaceuticals Inc rank is 221
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Dicerna Pharmaceuticals Inc is ranked 365.
90 Day Gain
Dicerna Pharmaceuticals Inc rank is 1049
Debt-to-Equity
Dicerna Pharmaceuticals Inc rank is 2016
Negative Rankings
Price-to-Sales
Dicerna Pharmaceuticals Inc rank is 95
Negative Net Margin
Dicerna Pharmaceuticals Inc rank is 159
Negative ROE
Dicerna Pharmaceuticals Inc rank is 674
High Put/Call
Dicerna Pharmaceuticals Inc has a high Put/Call ratio of 1.06 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Dicerna Pharmaceuticals Inc is ranked 778.
Negative ROA
Dicerna Pharmaceuticals Inc rank is 868
Down EPS Surprise
Dicerna Pharmaceuticals Inc missed the consensus earnings estimate when it last reported quarterly earnings.
Negative Cash Growth
Dicerna Pharmaceuticals Inc rank is 1082
Price-to-Book
Dicerna Pharmaceuticals Inc rank is 1141
High vPut/Call
Dicerna Pharmaceuticals Inc has a high Put/Call ratio of 1.00 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Dicerna Pharmaceuticals Inc is ranked 1408.
Down EPS Surprise
Dicerna Pharmaceuticals Inc missed the consensus earnings estimate when it last reported quarterly earnings.







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.